JBIO · Jade Biosciences, Inc. · Investor Relations
$15.13
+0.27 (+1.82%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$962.23M
Shares
63.60M
Volume · Oct 21
932.74K
Avg daily vol (3M)
902.38K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-30 | Jade Biosciences: JADE301 Webcast | Webcast |
| 2026-09-23 | Stifel Virtual Immunology and Inflammation Forum | Webcast |
| 2026-09-14 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-09-09 | Citi 2026 Biopharma Back to School Summit | Webcast |
| 2026-09-08 | Wells Fargo 21st Annual Healthcare Conference | Conference |
| 2026-06-01 | Jade Biosciences Conference Call & Webcast | Conference |
| 2026-04-21 | 2026 Bloom Burton & Co. Healthcare Investor Conference | Conference |
| 2026-03-10 | Jefferies Biotech on the Beach Summit | Event |
| 2026-03-08 | Leerink Global Healthcare Conference | Conference |
| 2026-03-02 | TD Cowen 46th Annual Health Care Conference | Conference |
Key facts
CIK
1798749
CUSIP
008064206
13F (30d)
11 filings
11 filers
Visit website
Investor relations